Pharmaceuticals

Drug Development

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized?

Weight-loss drug Wegovy could help treat alcohol addiction, researchers say

Wegovy Alcohol Addiction

Drug wholesaler AmerisourceBergen to change name amid expansion plans

AmerisourceBergen Cencora

Johnson & Johnson will separate consumer products business into new company

Johnson & Johnson company spinoff

New lupus drug with fewer side effects approved by FDA

New Lupus drug FDA

Bucks County drug manufacturer, execs charged with conspiracy to defraud FDA

KVK-TECH FDA

Regeneron seeks expanded use of its COVID-19 antibody cocktail for prevention of COVID-19

New drug stops COVID-19 from spreading in nursing homes, drug maker says

Eli Lily Nursing Home Treatment

Penn research signals progress toward future anti-obesity drugs

Obesity Penn Research

Doctors in Thailand treat coronavirus with anti-viral cocktail of HIV drugs and Tamiflu

HIV Flu drugs treat Coronavirus

Temple researchers make progress on alternative to opioids for chronic pain treatment

Temple TRPA1

Philly-based Spark Therapeutics acquired by Roche in $4.3 billion deal

Spark Therapeutics PHL

Batch of Xanax medication recalled due to 'foreign substance'

Xanax pharma

Study links blood pressure medication to suicide risk, but some health experts are skeptical

blood pressure medication suicide

Pharma pours cash on Congress as battles over drug prices persist

U.S. Capitol: Pharma pouring cash on Congress as drug price battles rage

Health Insurance

Type 1 diabetics decry rising costs of life-saving insulin

Diabetes Forum Insulin Costs

Pneumonia treatment by King of Prussia company gets FDA approval

xenleta king of prussia

Will I always face the threat of a peanut-laden kiss of death?

01112019_pb&j_Flickr

Johnson & Johnson failed to disclose asbestos in its Baby Powder, report says

12142018_johnson_baby_powder_Flickr

Pushing PrEP: Planned Parenthood targets gay men and heterosexual women

New epilepsy treatment is the first FDA-approved cannabis-based drug

Carroll - NJ Marijuana Dispensary

Thousands of birth control packs recalled for incorrectly placed placebo pills

Customers nationwide reporting EpiPen shortages

epipen mylan

Philly sues pharmaceutical companies claiming they have liability in opioid crisis

Sozi Pedro Tulante

Is there a difference between generic and name-brand ibuprofen?

An overlooked epidemic: Older Americans taking too many unneeded drugs

Pharmaceuticals

Jefferson clinical trial shows promise for new migraine therapy

Stock_Carroll - Thomas Jefferson Hospital

Antibiotics can be unnecessary and potentially harmful, IBC says

Pharmaceuticals

Women fear drug they used to halt puberty led to health problems

GlaxoSmithKline appoints insider as first female CEO

Emma Walmsley

Going to the dentist could soon mean no Novocain, no needle

09162016_spray_StRen

Pharmaceuticals

Inventing a machine that spits out drugs in a whole new way

05302016_drugmaker_machine_MIT

FDA approves first drug in U.S. for Parkinson's-related psychosis

Drexel seeks healthy participants for landmark Alzheimer's drug study

Urban Medicare beneficiaries may see more drug savings this year

Five scientists indicted in alleged theft of GlaxoSmithKline trade secrets

012016_Biopharmaceuticals

Delco pharma company expands outside U.S.

Manufacturing pills

Lawsuit seeks support for kids in unplanned pregnancies caused by birth control blunder

Philly firm scores legal victory against maker of drug that caused male breast growth

Pharmaceuticals

Endo becomes 5th-largest generic drug company in US

23 men, two women in alcohol safety study for FDA-approved female ‘Viagra’

Friends

Licensing deal for PA lab's cancer vaccine worth up to $700M

Pharmaceuticals

Teva recalls cancer drug for a second time

Page 1 of 2 next

Just In

The contents of this website, such as text, graphics, images, and other material contained on this website, are for informational purposes only and do not constitute medical advice.

ahealthierphilly is sponsored by Independence Blue Cross, the leading health insurance organization in Southeastern Pennsylvania, serving nearly 2.5 million people in the region, providing health news and related information that leads to a more informed, healthier life.

ahealthierphilly and its health-related information resources are not a substitute for the medical advice, diagnosis, and treatment that patients receive from their physicians or health care providers and are not meant to be the practice of medicine, the practice of nursing, or to carry out any professional health care advice or service in the state where you live. Nothing in this website is meant to be used for medical or nursing diagnosis or professional treatment.

Always seek the advice of your physician or other licensed health care provider. Always consult your health care provider before beginning any new treatment, or if you have any questions regarding your health condition. You should not disregard medical advice, or delay seeking medical advice, because of something you read on this site. In the event of a medical emergency, call a doctor or 911 immediately.

This website does not recommend or endorse any specific tests, physicians, procedures, opinions, or other information that may be mentioned on this website. Descriptions of, references to, or links to other products, publications, or services does not imply endorsement of any kind. Reliance on any information provided by this website is solely at your own risk.

Although we try to keep the information on the site as accurate as possible, ahealthierphilly disclaims any warranty concerning its accuracy, timeliness and completeness of content, and any other warranty, express or implied, including warranties of merchantability or fitness for a particular purpose. ahealthierphilly also reserves the right to temporarily or permanently discontinue this website, any page or any functionality at any time and without any notice.

The website and its content are provided on an “as is” basis.

© 2024 WWB Holdings, LLC. All rights reserved